脑部放疗，上午比下午敏感许多！
0 T1 N' T( ^) n+ d; t+ f( P# f
, p V @& g. l5 h# d E4 [7 F. a3 ?9 g7 p' F3 S7 R1 E% N
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9./ N3 L5 ^7 V0 C6 x: ^3 h
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
) c& B5 k$ L9 ?* oRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.& m2 p f% s* o2 F, Y
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA. ?; t9 p- | `+ [, r/ S8 |
( J/ Q5 c4 V1 Y; O5 a; Q2 X
Abstract" J, t# O6 b' P/ }8 y4 j0 s! @
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
6 S$ f4 ]8 }& h# W$ M' H6 _1 k
0 s! n+ k" @( \9 vMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.. q6 x4 l7 O* X" L2 m; G0 o
4 q4 ^0 q# r+ `+ q* n) W6 S
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). b# R. F }1 u0 m! E
, \' U; T9 k1 P9 F+ v' h
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.1 Q2 C/ s; X9 K9 E0 l) @3 m: x7 w
+ t7 b: y1 s9 g/ e W |
显身卡
